Texas Biomed working to accelerate COVID-19 drug development | 麻豆传媒: 麻豆传媒 for Journalists

Credit: Texas Biomed

Texas Biomed Professor Luis Martinez-Sobrido and his lab have received approval from NIH-OSP to work with a weakened version of SARS-CoV-2 in BSL-2 settings.

« Texas Biomed working to accelerate COVID-19 drug development

Credit: Texas Biomed

Texas Biomed Staff Scientist Chengjin Ye, PhD, is a co-inventor with Professor Luis Martinez-Sobirdo on a patent application for their reverse genetics approaches to generate recombinant SARS-CoV-2, including attenuated forms for use as live-attenuated COVID-19 vaccines.

« Texas Biomed working to accelerate COVID-19 drug development

0.05882

麻豆传媒

Expert Pitch

Expert Query

Expert Directory